Clinical tool accurately classifies benign and malignant spots on lung scans of smokers

Terry Fox Research Institute-led study assesses new software

2013-09-05

(Press-News.org) This news release is available in French.

Vancouver, BC – A Terry Fox Research Institute(TFRI)-led study has developed a new clinical risk calculator software that accurately classifies, nine out of ten times, which spots or lesions (nodules) are benign and malignant on an initial lung computed tomography (CT) scan among individuals at high risk for lung cancer.

The findings are expected to have immediate clinical impact worldwide among health professionals who currently diagnose and treat individuals at risk for or who are diagnosed with lung cancer, and provide new evidence for developing and improving lung-cancer screening programs. A total of 12,029 lung cancer nodules observed on CTs of 2,961 current and former smokers were examined in the population-based study.

The results, to be published in the Sept. 5th issue of the New England Journal of Medicine (NEJM), will have an immediate impact on clinical practice, says co-principal investigator Dr. Stephen Lam, chair of BC's Provincial Lung Tumour Group at the BC Cancer Agency and a professor of medicine at the University of British Columbia.

"We already know that CT screening saves lives. Now, we have evidence that our model and risk calculator can accurately predict which abnormalities that show up on a first CT require further follow up, such as a repeat CT scan, a biopsy, or surgery, and which ones do not. This is extremely good news for everyone – from the people who are high risk for developing lung cancer to the radiologists, respirologists and thoracic surgeons who detect and treat it. Currently, there are no Canadian guidelines for us to use in clinical practice."

In countries where guidelines do exist, they largely relate to nodule size. The pan-Canadian team's prediction model, developed by Brock University epidemiologist Dr. Martin Tammemägi, includes a risk calculator that considers several factors in addition to size: older age, female sex, family history of lung cancer, emphysema, location of the nodule in the upper lobe, part-solid nodule type, lower nodule count and spiculation (presence of sharp or needle-like points). "Reducing the number of needless tests and increasing rapid, intensive diagnostic workups in individuals with high-risk nodules are major goals of the model," says Dr. Tammemägi.

The TFRI team used two sets of data to determine their findings, studying a total of 12,029 nodules from 2,961 persons – current and former smokers, aged 50-75, who had undergone low-dose CT screening. One set involved participants in the TFRI Pan-Canadian Early Detection of Lung Cancer Study from 2008 to 2010, where 1,871 persons with a total of 7,008 nodules (102 of which were malignant) were screened and followed. The other set involved 1,090 persons with 5,021 nodules (of which 42 were malignant) who took part in several lung cancer prevention trials conducted by the BC Cancer Agency during 2000-2010 and were funded through the U.S. National Cancer Institute (NCI). In the former study, participants were followed for an average of three years; in the latter, for an average of eight-and-a-half years.

Dr. Lam says the prediction model holds up even in cases where clinicians are faced with the toughest challenges; for example, deciding what to do when nodules are one centimeter (the approximate width of an adult thumbnail) or smaller. While nodule size is one predictor of lung cancer, the largest nodule appearing on the CT was not necessarily cancerous. The pan-Canadian study team found that nodules located in the upper lobes of the lung carry an increased probability of cancer. In both data sets studied, researchers found that where cancer was present, fewer nodules were found. This model will simplify the work involved, especially for radiologists, in evaluating and assessing nodules on scans, as well as respirologists and thoracic surgeons who must make decisions about tests and treatment for their patients.

"An accurate and practical model that can predict the probability that a lung nodule is malignant and that can be used to guide clinical decision making will reduce costs and the risk of morbidity and mortality in screening programs," wrote Dr. Lam and study colleagues in the article, titled: Probability of Cancer in Pulmonary Nodules Detected on First Screening Computed Tomography."

"The findings in this study bolster the potential for the successful implementation of a lung cancer screening program using low-dose computed tomography (CT) within a high-risk population. This tool, combined with CT-screening, will increase our success in earlier detection, diagnosis and treatment of the disease. Further, this model combined with new guidelines for best clinical practice, will provide our health care system with both effective and affordable tools to implement such a program," says Nova Scotia thoracic surgeon Dr. Michael Johnston, a member of the study team. Dr. Johnston serves on the executive of the Terry Fox Research Institute and is chair of the medical advisory committee of Lung Cancer Canada.

"Many jurisdictions throughout the world are now considering whether or how to best implement lung cancer screening. Studies like this one are key to answering important questions so decisions are most likely to result in good practice and planning, and ultimately benefit patients," says Dr. Heather Bryant, vice-president, cancer control at the Canadian Partnership Against Cancer.

The significant findings come on the heels of the U.S. National Lung Screening Trial (2011) that found a 20% reduction in lung cancer mortality with the use of low-dose thoracic computed tomography.

Dr. Christine Berg, co-principal investigator of the National Lung Screening Trial and former chief, Early Detection Research Group, division of cancer prevention, for the National Cancer Institute in the United States, says: "This important work of Dr. Lam and colleagues is a major advance for clinicians performing lung cancer screening. They provide a tool to grapple with the problem of the high rate of positive low-dose computed tomography scans. Fewer follow-up scans with their attendant cost and fewer biopsies with their complications will need to be performed while continuing to diagnosis lung cancer at an early stage to lower mortality. Coupled with continued public health efforts to lower cigarette smoking, this work will have international impact on the leading cause of cancer death worldwide."

INFORMATION:

The Pan-Canadian study is funded by the TFRI, the research arm of the Terry Fox Foundation, and the Canadian Partnership Against Cancer. The BCCA study was supported by the United States Public Health Service National Cancer Institute. In Canada, lung cancer kills over 20,000 Canadians annually. It is the primary cause of cancer deaths in Canada. One in 12 Canadians will receive a lung cancer diagnosis in his or her lifetime. With early detection, five-year survival rates can be over 70%.

About TFRI/TFF: Launched in October 2007, The Terry Fox Research Institute (TFRI) is the brainchild of The Terry Fox Foundation (TFF). TFRI seeks to improve significantly the outcomes of cancer research for the patient through a highly collaborative, team-oriented, milestone-based approach to research that will enable discoveries to translate quickly into practical solutions for cancer patients worldwide. TFRI collaborates with over 50 cancer hospitals and research organizations across Canada. The Terry Fox Foundation (TFF) maintains the vision and principles of Terry Fox while raising money for cancer research through the annual Terry Fox Run, National School Run Day and other fundraising initiatives which, to date, have raised over $600 million worldwide. The 33rd Terry Fox Run will take place across Canada at more than 800 community sites on Sunday, September 15. For more information, visit http://www.tfri.ca and http://www.terryfox.org

For more information, please contact:

Kelly Curwin, Chief Communications Officer
Terry Fox Research Institute
Office: 604-675-8223
Cell: 778-237-8158
kcurwin@tfri.ca

Lenore Bromley, Media Relations
Canadian Partnership Against Cancer
416-915-9222 ext. 5781
Cell: 416-710-9294
lenore.bromley@partnershipagainstcancer.ca

Jenn Currie, Communications Officer,
BC Cancer Agency
Provincial Health Services Authority
604-675-8106
Cell: 778-877-6643
jenn.currie@bccancer.bc.ca

Cathy Majtenyi, Research Communications/Media Relations Specialist
Brock University
905-688-5550 ext. 5789
Cell: 905-321-0566
cmajtenyi@brocku.ca

Dr. Lam is available for media interviews
Other experts available for comment:
Dr. Martin C. Tammemägi, Brock University
Dr. Heather Bryant, Canadian Partnership Against Cancer
Dr. Christine Berg, Co-Principal Investigator, US National Lung Screening Trial

Related photos and video(b-roll) available at http://www.tfri.ca

ELSE PRESS RELEASES FROM THIS DATE:

Heart attack death rates unchanged in spite of faster care at hospitals

2013-09-05

ANN ARBOR, Mich. -- Heart attack deaths have remained the same, even as hospital teams have gotten faster at treating heart attack patients with emergency angioplasty, according to a study in this week's New England Journal of Medicine. Hospitals across the country have successfully raced to reduce so-called door-to-balloon time, the time it takes patients arriving at hospitals suffering from a heart attack to be treated with angioplasty, to 90 minutes or less in the belief that it would save heart muscle and lives. In an analysis led by the University of Michigan ...

Megabladder mouse model may help predict severity of pediatric kidney damage

2013-09-05

A new study of the megabladder mouse model suggests that tracking changes in the expression of key genes involved in kidney disease could help physicians predict the severity of urinary tract obstruction in pediatric patients, which could help identify children at the greatest risk of chronic kidney disease and permanent organ damage. The work was led by a team that includes Brian Becknell, MD, PhD, a clinician and assistant professor in the Division of Nephrology at Nationwide Children's Hospital. The research, which tracked the expression of a number of genes related ...

TB and Parkinson's disease linked by unique protein

2013-09-05

A protein at the center of Parkinson’s disease research now also has been found to play a key role in causing the destruction of bacteria that cause tuberculosis, according to scientists led by UC San Francisco microbiologist and tuberculosis expert Jeffery Cox, PhD. The protein, named Parkin, already is the focus of intense investigation in Parkinson’s disease, in which its malfunction is associated with a loss of nerve cells. Cox and colleagues now report that Parkin also acts on tuberculosis, triggering destruction of the bacteria by immune cells known as macrophages. ...

MRI right before or after surgery does not benefit women with early breast cancer

2013-09-05

NEW YORK, September 4, 2013 — Memorial Sloan-Kettering Cancer Center study shows that the use of MRI before or immediately after surgery in women with DCIS was not associated with reduced local recurrence or contralateral breast cancer rates. The findings are being presented on Saturday, September 7, 2013, at the 2013 Breast Cancer Symposium. While no clinical practice guidelines exist for the use of MRI around the time of surgery, some surgeons use the screening tool to obtain a clearer picture of the cancer before surgery is performed or immediately after surgery to ...

A new view of brain tumors

2013-09-05

In the battle against brain cancer, doctors now have a new weapon -- a new imaging technology that will make brain surgery dramatically more accurate by allowing surgeons to distinguish -- at a microscopic level -- between brain tissue and tumors. Called SRS microscopy -- short for stimulated Raman scattering -- a team of researchers that included Xiaoliang Sunney Xie, the Mallinckrodt Professor of Chemistry and Chemical Biology and Minbiao Ji, a Post-Doctoral Fellow in Chemistry and Chemical Biology, were able to "see" the tiniest areas of tumor cells in brain tissue, ...

Researchers discover a new pathway in blood vessel inflammation and disease

2013-09-05

Case Western Reserve researchers have identified a genetic factor that blocks the blood vessel inflammation that can lead to heart attacks, strokes and other potentially life-threatening events. The breakthrough involving Kruppel-like factor (KLF) 15 is the latest in a string of discoveries from the laboratory of professor of medicine Mukesh K. Jain that involves a remarkable genetic family. Kruppel-like factors appear to play prominent roles in everything from cardiac health and obesity to metabolism and childhood muscular dystrophy. School of Medicine instructor ...

West Antarctica ice sheet existed 20 million years earlier than previously thought

2013-09-05

(Santa Barbara, Calif.) –– The results of research conducted by professors at UC Santa Barbara and colleagues mark the beginning of a new paradigm for our understanding of the history of Earth's great global ice sheets. The research shows that, contrary to the popularly held scientific view, an ice sheet on West Antarctica existed 20 million years earlier than previously thought. The findings indicate that ice sheets first grew on the West Antarctic subcontinent at the start of a global transition from warm greenhouse conditions to a cool icehouse climate 34 million years ...

Sharing the risks/costs of biomass crops

2013-09-05

URBANA, Ill. – Farmers who grow corn and soybeans can take advantage of government price support programs and crop insurance, but similar programs are not available for those who grow biomass crops such as Miscanthus. A University of Illinois study recommends a framework for contracts between growers and biorefineries to help spell out expectations for sustainability practices and designate who will assume the risks and costs associated with these new perennial energy crops. "The current biomass market operates more along the lines of a take-it-or-leave-it contract, ...

Infrared NASA image sees Extra-Tropical Toraji over Japan

2013-09-05

Tropical Storm Toraji passed over Kyushu and transitioned into an extra-tropical storm while bringing heavy rainfall over the big island of Japan when NASA's Aqua satellite passed overhead on Sept. 4. The extra-tropical storm is now a cold-core system being carried by a frontal system. The Atmospheric Infrared Sounder or AIRS instrument captured infrared data of Extra-Tropical Storm Toraji as it continued tracking through southern Japan on Sept.4 at 0429 UTC/12:29 a.m. EDT. AIRS showed that the coldest cloud top temperatures and strongest thunderstorms with heaviest rainfall ...

Electronics advance moves closer to a world beyond silicon

2013-09-05

CORVALLIS, Ore. – Researchers in the College of Engineering at Oregon State University have made a significant advance in the function of metal-insulator-metal, or MIM diodes, a technology premised on the assumption that the speed of electrons moving through silicon is simply too slow. For the extraordinary speed envisioned in some future electronics applications, these innovative diodes solve problems that would not be possible with silicon-based materials as a limiting factor. The new diodes consist of a "sandwich" of two metals, with two insulators in between, to ...

LAST 30 PRESS RELEASES:

AI finds undiagnosed liver disease in early stages

The American Society of Tropical Medicine and Hygiene and the Bill & Melinda Gates Foundation announce new research fellowship in malaria genomics in honor of professor Dominic Kwiatkowski